NIH Common Data Elements (CDE) Repository

Permissible Values:

Value	Code Name	Code Description
0	No resistance throughout the course of the passive movement	No resistance throughout the course of the passive movement
1	Slight resistance throughout the course of passive movement, no clear catch at a precise angle	Slight resistance throughout the course of passive movement, no clear catch at a precise angle
2	Clear catch at a precise angle, interrupting the passive movement, followed by release	Clear catch at a precise angle, interrupting the passive movement, followed by release
3	Fatigable clonus with less than 10 seconds when maintaining the pressure and appearing at the precise angle	Fatigable clonus with less than 10 seconds when maintaining the pressure and appearing at the precise angle
4	Unfatigable clonus with more than 10 seconds when maintaining the pressure and appearing at a precise angle	Unfatigable clonus with more than 10 seconds when maintaining the pressure and appearing at a precise angle
5	Joint is immovable (Indicate which assistive device the participant uses)	Joint is immovable (Indicate which assistive device the participant uses)

ID:
Title:
URI:
Provider Org:
Language Code:
Document:: Key Reference: Key Reference: Tardieu G, Shentoub S, Delarue R. (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris), 91(2): 143–144. Other References: Ansari, N. N., Naghdi, S., Hasson, S., Azarsa, M. H., & Azarnia, S. (2008). The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Inj, 22(13-14), 1007–1012. Boyd, R., & Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with CP. Eur J Neurol, 6(Suppol 4), S23–S35. Gracies, J. M., Burke, K., Clegg, N. J., Browne, R., Rushing, C., Fehlings, D., . . . Delgado, M. R. (2010). Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Arch Phys Med Rehabil, 91(3), 421–428. Haugh AB, Pandyan AD, Johnson GR. (2006). A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil, 28(15): 899–907. Morris, S. (2002). Ashworth And Tardieu Scales: Their Clinical Relevance For Measuring Spasticity In Adult And Paediatric Neurological Populations. Phys Ther Rev, 7(1), 53–62.

ID:
Title:
URI:
Provider Org:
Language Code:
Document:: Key Reference: Tardieu G, Shentoub S, Delarue R. (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris), 91(2): 143–144. Other References: Ansari, N. N., Naghdi, S., Hasson, S., Azarsa, M. H., & Azarnia, S. (2008). The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Inj, 22(13-14), 1007–1012. Boyd, R., & Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with CP. Eur J Neurol, 6(Suppol 4), S23–S35. Gracies, J. M., Burke, K., Clegg, N. J., Browne, R., Rushing, C., Fehlings, D., . . . Delgado, M. R. (2010). Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Arch Phys Med Rehabil, 91(3), 421–428. Haugh AB, Pandyan AD, Johnson GR. (2006). A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil, 28(15): 899–907. Morris, S. (2002). Ashworth And Tardieu Scales: Their Clinical Relevance For Measuring Spasticity In Adult And Paediatric Neurological Populations. Phys Ther Rev, 7(1), 53–62.